KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells
- 1 March 2017
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 484 (3) , 486-492
Abstract
No abstract availableKeywords
Funding Information
- West Cancer Center
This publication has 31 references indexed in Scilit:
- An international assessment of ovarian cancer incidence and mortalityGynecologic Oncology, 2013
- Detection and monitoring of ovarian cancerClinica Chimica Acta, 2013
- KLF4 overexpression and apigenin treatment down regulated anti‐apoptotic Bcl‐2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK‐N‐DZ and IMR‐32 cellsMolecular Oncology, 2012
- Krüppel-Like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug ExpressionPLOS ONE, 2012
- Generation of Induced Pluripotent Stem Cells From Buffalo ( Bubalus bubalis ) Fetal Fibroblasts with Buffalo Defined FactorsStem Cells and Development, 2012
- Krüppel‐like factor 4 functions as a tumor suppressor in cervical carcinomaCancer, 2011
- Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasionOncogene, 2011
- KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal CarcinomaThe American Journal of Pathology, 2011
- KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphomaBlood, 2010
- KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expressionCancer Biology & Therapy, 2010